Genetic variants of CBP and SOX9 to predict clinical outcome in metastatic colorectal cancer (mCRC) patients (pts) treated with first-line FOLFIRI and bevacizumab (FOLFIRI/BEV).
作者： Yan Ning , Wu Zhang , Dongyun Yang , Sebastian Stintzing , Yu Sunakawa
DOI: 10.1200/JCO.2014.32.15_SUPPL.E14528
关键词:
摘要: e14528 Background: Wnt signaling pathways play divergent roles during development, normal homeostasis and disease. The Cancer Genome Atlas Network (TCGA) CRC data showed pathway genes...
sci-hub.st 参考文章(0)